QQQ   319.43 (-2.79%)
AAPL   142.06 (-0.77%)
MSFT   232.90 (+0.25%)
FB   272.14 (-3.51%)
GOOGL   1,818.94 (-4.67%)
AMZN   3,232.58 (-2.81%)
TSLA   864.16 (-2.14%)
NVDA   516.71 (-3.85%)
BABA   260.25 (-2.13%)
CGC   37.83 (+6.50%)
GE   11.38 (+0.80%)
MU   75.09 (-5.56%)
AMD   88.84 (-6.20%)
NIO   57.15 (-5.24%)
T   29.14 (-2.05%)
F   10.79 (-3.57%)
ACB   11.20 (+4.97%)
BA   194.03 (-3.97%)
DIS   163.03 (-3.85%)
NFLX   523.28 (-6.88%)
GILD   65.48 (-1.83%)
QQQ   319.43 (-2.79%)
AAPL   142.06 (-0.77%)
MSFT   232.90 (+0.25%)
FB   272.14 (-3.51%)
GOOGL   1,818.94 (-4.67%)
AMZN   3,232.58 (-2.81%)
TSLA   864.16 (-2.14%)
NVDA   516.71 (-3.85%)
BABA   260.25 (-2.13%)
CGC   37.83 (+6.50%)
GE   11.38 (+0.80%)
MU   75.09 (-5.56%)
AMD   88.84 (-6.20%)
NIO   57.15 (-5.24%)
T   29.14 (-2.05%)
F   10.79 (-3.57%)
ACB   11.20 (+4.97%)
BA   194.03 (-3.97%)
DIS   163.03 (-3.85%)
NFLX   523.28 (-6.88%)
GILD   65.48 (-1.83%)
QQQ   319.43 (-2.79%)
AAPL   142.06 (-0.77%)
MSFT   232.90 (+0.25%)
FB   272.14 (-3.51%)
GOOGL   1,818.94 (-4.67%)
AMZN   3,232.58 (-2.81%)
TSLA   864.16 (-2.14%)
NVDA   516.71 (-3.85%)
BABA   260.25 (-2.13%)
CGC   37.83 (+6.50%)
GE   11.38 (+0.80%)
MU   75.09 (-5.56%)
AMD   88.84 (-6.20%)
NIO   57.15 (-5.24%)
T   29.14 (-2.05%)
F   10.79 (-3.57%)
ACB   11.20 (+4.97%)
BA   194.03 (-3.97%)
DIS   163.03 (-3.85%)
NFLX   523.28 (-6.88%)
GILD   65.48 (-1.83%)
QQQ   319.43 (-2.79%)
AAPL   142.06 (-0.77%)
MSFT   232.90 (+0.25%)
FB   272.14 (-3.51%)
GOOGL   1,818.94 (-4.67%)
AMZN   3,232.58 (-2.81%)
TSLA   864.16 (-2.14%)
NVDA   516.71 (-3.85%)
BABA   260.25 (-2.13%)
CGC   37.83 (+6.50%)
GE   11.38 (+0.80%)
MU   75.09 (-5.56%)
AMD   88.84 (-6.20%)
NIO   57.15 (-5.24%)
T   29.14 (-2.05%)
F   10.79 (-3.57%)
ACB   11.20 (+4.97%)
BA   194.03 (-3.97%)
DIS   163.03 (-3.85%)
NFLX   523.28 (-6.88%)
GILD   65.48 (-1.83%)
Log in
NASDAQ:AXLA

Axcella Health Stock Forecast, Price & News

$5.48
-0.30 (-5.19 %)
(As of 01/27/2021 12:00 AM ET)
Add
Compare
Today's Range
$5.40
Now: $5.48
$5.85
50-Day Range
$5.04
MA: $5.52
$5.99
52-Week Range
$2.25
Now: $5.48
$7.73
Volume75,326 shs
Average Volume82,637 shs
Market Capitalization$205.72 million
P/E RatioN/A
Dividend YieldN/A
Beta1.53
Axcella Health Inc., a clinical-stage biotechnology company, researches and develops endogenous metabolic modulators (EMMs) for the treatment of complex diseases and improving health in the United States. It offers AXA1665 for use in treating overt hepatic encephalopathy; AXA1125 and AXA1957 to treat non-alcoholic steatohepatitis; AXA2678 for use in treating muscle atrophy; and AXA4010 to target multiple biological pathways to support normal structures and functions of the blood. The company was formerly known as Newco LS16, Inc. and changed its name to Axcella Health Inc. in June 2016. Axcella Health Inc. was founded in 2008 and is based in Cambridge, Massachusetts.

MarketRank

Overall MarketRank

1.58 out of 5 stars

Medical Sector

324th out of 1,926 stocks

Biological Products, Except Diagnostic Industry

42nd out of 177 stocks

Analyst Opinion: 3.4Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:AXLA
CUSIPN/A
CIKN/A
Phone857-320-2200
Employees66
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value$2.61 per share

Profitability

Net Income$-59,040,000.00

Miscellaneous

Market Cap$205.72 million
Next Earnings Date3/22/2021 (Estimated)
OptionableNot Optionable
$5.48
-0.30 (-5.19 %)
(As of 01/27/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AXLA News and Ratings via Email

Sign-up to receive the latest news and ratings for AXLA and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Axcella Health (NASDAQ:AXLA) Frequently Asked Questions

How has Axcella Health's stock price been impacted by Coronavirus?

Axcella Health's stock was trading at $3.32 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, AXLA stock has increased by 65.1% and is now trading at $5.48.
View which stocks have been most impacted by COVID-19
.

Is Axcella Health a buy right now?

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Axcella Health in the last twelve months. There are currently 1 hold rating and 8 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Axcella Health stock.
View analyst ratings for Axcella Health
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Axcella Health?

Wall Street analysts have given Axcella Health a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Axcella Health wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What is Bill Hinshaw's approval rating as Axcella Health's CEO?

3 employees have rated Axcella Health CEO Bill Hinshaw on Glassdoor.com. Bill Hinshaw has an approval rating of 100% among Axcella Health's employees. This puts Bill Hinshaw in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

When is Axcella Health's next earnings date?

Axcella Health is scheduled to release its next quarterly earnings announcement on Monday, March 22nd 2021.
View our earnings forecast for Axcella Health
.

How were Axcella Health's earnings last quarter?

Axcella Health Inc. (NASDAQ:AXLA) announced its earnings results on Tuesday, November, 17th. The company reported ($0.34) earnings per share for the quarter, topping the Zacks' consensus estimate of ($0.41) by $0.07.
View Axcella Health's earnings history
.

What price target have analysts set for AXLA?

9 brokers have issued 1 year target prices for Axcella Health's stock. Their forecasts range from $9.00 to $28.00. On average, they anticipate Axcella Health's share price to reach $17.13 in the next year. This suggests a possible upside of 212.5% from the stock's current price.
View analysts' price targets for Axcella Health
or view Wall Street analyst' top-rated stocks.

Are investors shorting Axcella Health?

Axcella Health saw a increase in short interest in the month of December. As of December 31st, there was short interest totaling 332,000 shares, an increase of 19.3% from the December 15th total of 278,400 shares. Based on an average trading volume of 95,400 shares, the days-to-cover ratio is currently 3.5 days. Currently, 2.1% of the company's shares are sold short.
View Axcella Health's Short Interest
.

Who are some of Axcella Health's key competitors?

What other stocks do shareholders of Axcella Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Axcella Health investors own include Sorrento Therapeutics (SRNE), VBI Vaccines (VBIV), Evofem Biosciences (EVFM), ADMA Biologics (ADMA), Coty (COTY), Energy Transfer (ET), Myovant Sciences (MYOV), NVIDIA (NVDA), Pfizer (PFE) and Moderna (MRNA).

Who are Axcella Health's key executives?

Axcella Health's management team includes the following people:
  • Mr. William R. Hinshaw Jr., Pres, CEO & Director (Age 52, Pay $785.48k)
  • Dr. Manu V. Chakravarthy M.D., Ph.D., Exec. VP of Clinical Devel. & Chief Medical Officer (Age 47, Pay $529.21k)
  • Mr. Laurent Chardonnet, Sr. VP & CFO (Age 56)
  • Dr. Paul Fehlner J.D., Ph.D., Sr. VP, Chief Legal Officer & Corp. Sec. (Age 57)
  • Mr. Andrew J. Suchoff, Sr. VP & Chief People Officer
  • Dr. Larry Bell, Global Head of Regulatory Affairs & Pharmacovigilance and Sr. VP

When did Axcella Health IPO?

(AXLA) raised $76 million in an IPO on Thursday, May 9th 2019. The company issued 3,600,000 shares at $20.00-$22.00 per share. Goldman Sachs, J.P. Morgan and SVB Leerink served as the underwriters for the IPO.

What is Axcella Health's stock symbol?

Axcella Health trades on the NASDAQ under the ticker symbol "AXLA."

How do I buy shares of Axcella Health?

Shares of AXLA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Axcella Health's stock price today?

One share of AXLA stock can currently be purchased for approximately $5.48.

How big of a company is Axcella Health?

Axcella Health has a market capitalization of $205.72 million. The company earns $-59,040,000.00 in net income (profit) each year or ($3.55) on an earnings per share basis. Axcella Health employs 66 workers across the globe.

What is Axcella Health's official website?

The official website for Axcella Health is www.axcellahealth.com.

How can I contact Axcella Health?

Axcella Health's mailing address is 840 MEMORIAL DRIVE, CAMBRIDGE MA, 02139. The company can be reached via phone at 857-320-2200 or via email at [email protected]

This page was last updated on 1/27/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.